Indaptus Therapeutics, Inc
Decoy20
Solid Tumor, Adult
Countdown
358days
Phase 2 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 2 trial results for Decoy20 in Solid Tumor, Adult are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT05651022: Phase 2 trial, sponsor Indaptus Therapeutics, Inc, drug Decoy20. Primary completion date 2027-06-30 (estimated).”